48802-3

LOINC 2.82

Alpha-1-Fetoprotein panel - Serum or Plasma

AFP Pnl SerPl

Definition

  • Performed at 16-18 weeks' gestation on mothers who have early amniocentesis, chorionic villous sampling or 1st trimester screening. Screening for Open Neural Tube defects (e.g. spinal bifida). Other defects may also be detected.

Component

  • Alpha-1-fetoprotein panel

Specimen / system

  • Ser/Plas

Class

  • PANEL.CHEM

Property

  • -

Scale

  • -

Related names

  • A1; AFP; AFP Pnl; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; Feto; i; Maternal screen; Maternal screen 1; Maternal screen for neural tube defect; msAFP; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Single marker screen; SR; Tumor marker; UniversalLabOrders

Index terms

  • A1
  • AFP
  • AFP Pnl
  • Alfa
  • Alpha fetoprotein
  • Alphafetoprotein
  • Chemistry
  • Feto
  • i
  • Maternal screen
  • Maternal screen 1
  • Maternal screen for neural tube defect
  • msAFP
  • Pan
  • PANEL.CHEMISTRY
  • Panl
  • Pl
  • Plasma
  • Plsm
  • Pnl
  • Point in time
  • Random
  • SerP
  • SerPl
  • SerPlas
  • Serum
  • Serum or plasma
  • Single marker screen
  • SR
  • Tumor marker
  • UniversalLabOrders